ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01785771
Recruitment Status : Terminated (Decision by Sponsor)
First Posted : February 7, 2013
Last Update Posted : January 30, 2018
Sponsor:
Information provided by (Responsible Party):
Intarcia Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2018
  Actual Study Completion Date : January 2018